Emmanuel Caeymaex
Corporate Officer/Principal en UCB .
Perfil
Emmanuel Caeymaex is currently the Executive VP & Head-Immunology Solutions at UCB SA. Previously, he worked as the Director at Dermira, Inc. in 2017 and as the President at UCB Japan Co. Ltd.
from 2006 to 2011.
He holds a graduate degree from Université Catholique de Louvain and CEMS The Global Alliance in Management Education.
Cargos activos de Emmanuel Caeymaex
| Empresas | Cargo | Inicio |
|---|---|---|
| UCB | Corporate Officer/Principal | 01/03/1994 |
Antiguos cargos conocidos de Emmanuel Caeymaex.
| Empresas | Cargo | Fin |
|---|---|---|
| DERMIRA, INC. | Director/Miembro de la Junta | 06/11/2017 |
| UCB Japan Co. Ltd. | Presidente | 01/06/2011 |
Formación de Emmanuel Caeymaex.
| Université Catholique de Louvain | Graduate Degree |
| CEMS The Global Alliance in Management Education | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| UCB | Health Technology |
| Empresas privadas | 2 |
|---|---|
| UCB Japan Co. Ltd. | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Bolsa de valores
- Insiders
- Emmanuel Caeymaex
